Recent molecular characterization of prostate cancer (PCa) identified novel genetic aberrations and disease subtypes. The frequencies of molecular aberrations show racial disparity. Clinical strategies and targeted therapies embracing these racial differences are required. Here we discuss ethnic differences in genetic alterations and their impact on the susceptibility, progression, and treatment of prostate cancer.

中文翻译：

---

前列腺癌中种族差异的分子鉴别器。

最近对前列腺癌 (PCa) 的分子表征确定了新的遗传畸变和疾病亚型。分子畸变的频率显示出种族差异。需要接受这些种族差异的临床策略和靶向治疗。在这里，我们讨论基因改变的种族差异及其对前列腺癌易感性、进展和治疗的影响。